VIVIAN APPIARIUS: Open Payments
NPI 1275806663 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,082 in 48 payments from 14 companies in 2025. Trend: 2023 $441 · 2024 $1,263 · 2025 $1,082
Food & beverage: $1,082
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 19 | $315 |
| SK Life Science, Inc. | 4 | $188 |
| LivaNova USA, Inc. | 3 | $119 |
| ABBVIE INC. | 6 | $102 |
| CATALYST PHARMACEUTICALS, INC. | 3 | $89 |
| JAZZ PHARMACEUTICALS INC. | 4 | $84 |
| Lundbeck LLC | 2 | $35 |
| Otter Pharmaceuticals, LLC | 1 | $29 |
| Neurelis, Inc. | 1 | $23 |
| Alexion Pharmaceuticals, Inc. | 1 | $22 |
Products named: Fintepla, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, XCOPRI, Nayzilam, FYCOMPA, EPIDIOLEX, Briviact, QULIPTA.
Industry payments across IN — which companies pay providers there.
